Crohn’s Disease Market Share, Size, Growth, Insight, Key Players, Research and Forecast – 2032
Ngày đăng: 05-09-2023 |
Ngày cập nhật: 05-09-2023
Crohn’s Disease Market Highlights:
The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 million Americans were diagnosed with Crohn's & ulcerative colitis disorders and diseases, with maximum of them aged above 30. Increasing occurrence of Crohn's disease market has triggered a vigorous demand for its therapeutics. A survey conducted by the US Centre for Disease Control (CDC) has discovered that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new cases per 100,000 population annually.
The Crohn’s disease market size was valued at USD 11.1 billion in 2022 and is projected to grow from USD 11.5 Billion in 2023 to USD 15.37 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.7% during the forecast period (2023 - 2032). Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune, and bacterial factors in genetically prone individuals. There are no medications, drugs or surgical procedures that can cure or prevent Crohn's disease. It is expected that the disease affects about 3.2 per 1,000 people in Europe and North America. It is less common in Asia and Africa. Rates have, however, been growing, particularly in the developing world, since last few years.
North America is expected to account for the largest share of the global Crohn’s disease Market in 2016, followed by Europe, the region will continue to lead the pack during the forecast period. The emerging periods of China and India will also play a key role in driving growth in the long term, primarily due to the anticipated strong uptake of Remicade over the forecast period.
The disease is highly predominant in developed countries, especially in individuals who smoke and consume alcohol.
Crohn’s disease is a chronic condition that causes inflammation and damage in the digestive tract. It is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, from the mouth to the anus, but most commonly involves the end of the small intestine (ileum) and the beginning of the large intestine (colon).
The symptoms of Crohn’s disease vary depending on the location and severity of the inflammation. Some common symptoms include abdominal pain, diarrhea, weight loss, fever, fatigue, blood in the stool, mouth sores, and anal fissures13. Crohn’s disease can also cause complications such as bowel obstruction, ulcers, fistulas, abscesses, malnutrition, and increased risk of colon cancer.
Market Segmentation:
Global Crohn’s Disease Market outlook is segmented based on procedures and drug type. Based on procedures, the market is segmented into Colonoscopy, flexible Sigmoidoscopy, Computerized Tomography (CT), surface coil magnetic resonance imaging (MRI), Capsule Endoscopy, Double-Balloon Endoscopy, Small Bowel Imaging. Colonoscopy due to high efficiency and accuracy is expected to command the largest market share during the forecasted period. Further based on drug type the market is classified into antibiotics, anti-diarrheal, immune system suppressors, pain relievers, and anti-inflammatory drugs. Antibiotics are expected to command the largest market share while anti-inflammatory drugs are expected to grow at the highest CAGR during the forecasted period.
Crohn’s Disease Market Players
Key players profiled in the report are Allergan, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, and Bayer AG, UCB S.A., Perrigo Company plc, Pfizer Inc., Johnson & Johnson Services, Inc., Ferring B.V.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 million Americans were diagnosed with Crohn's & ulcerative colitis disorders and diseases, with maximum of them aged above 30. Increasing occurrence of Crohn's disease market has triggered a vigorous demand for its therapeutics. A survey conducted by the US Centre for Disease Control (CDC) has discovered that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new cases per 100,000 population annually.
The Crohn’s disease market size was valued at USD 11.1 billion in 2022 and is projected to grow from USD 11.5 Billion in 2023 to USD 15.37 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.7% during the forecast period (2023 - 2032). Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune, and bacterial factors in genetically prone individuals. There are no medications, drugs or surgical procedures that can cure or prevent Crohn's disease. It is expected that the disease affects about 3.2 per 1,000 people in Europe and North America. It is less common in Asia and Africa. Rates have, however, been growing, particularly in the developing world, since last few years.
North America is expected to account for the largest share of the global Crohn’s disease Market in 2016, followed by Europe, the region will continue to lead the pack during the forecast period. The emerging periods of China and India will also play a key role in driving growth in the long term, primarily due to the anticipated strong uptake of Remicade over the forecast period.
The disease is highly predominant in developed countries, especially in individuals who smoke and consume alcohol.
Crohn’s disease is a chronic condition that causes inflammation and damage in the digestive tract. It is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract, from the mouth to the anus, but most commonly involves the end of the small intestine (ileum) and the beginning of the large intestine (colon).
The symptoms of Crohn’s disease vary depending on the location and severity of the inflammation. Some common symptoms include abdominal pain, diarrhea, weight loss, fever, fatigue, blood in the stool, mouth sores, and anal fissures13. Crohn’s disease can also cause complications such as bowel obstruction, ulcers, fistulas, abscesses, malnutrition, and increased risk of colon cancer.
Market Segmentation:
Global Crohn’s Disease Market outlook is segmented based on procedures and drug type. Based on procedures, the market is segmented into Colonoscopy, flexible Sigmoidoscopy, Computerized Tomography (CT), surface coil magnetic resonance imaging (MRI), Capsule Endoscopy, Double-Balloon Endoscopy, Small Bowel Imaging. Colonoscopy due to high efficiency and accuracy is expected to command the largest market share during the forecasted period. Further based on drug type the market is classified into antibiotics, anti-diarrheal, immune system suppressors, pain relievers, and anti-inflammatory drugs. Antibiotics are expected to command the largest market share while anti-inflammatory drugs are expected to grow at the highest CAGR during the forecasted period.
Crohn’s Disease Market Players
Key players profiled in the report are Allergan, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, and Bayer AG, UCB S.A., Perrigo Company plc, Pfizer Inc., Johnson & Johnson Services, Inc., Ferring B.V.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
